FCGR2B and neoplasm: Moreover, inhibition of FcγRIIB led to enhanced infiltration and activation of CD8+ T cells in gemcitabine-treated tumor-bearing mice (Figures 7D-F), suggesting that suppression of FcγRIIB could boost the anti-tumor response of chemotherapy.